A 5-year follow-up of the RENOVATE-COMPLEX-PCI trial demonstrates that intravascular imaging-guided PCI significantly reduces major adverse cardiac events by 32% compared to angiography alone in complex lesions, highlighting the long-term clinical benefits of procedural optimization.